Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults

A Phase 3, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine–Naïve Adults 18 Years of Age and Older

Category & Conditions:
Vaccine-related Conditions
Medicine:
PF-06482077
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7471007
Open Plain Language Summary Result:Click here